Regression of abdominal aortic aneurysm by inhibition of c‐Jun N‐terminal kinase in mice
K Yoshimura, H Aoki, Y Ikeda, A Furutani… - Annals of the New …, 2006 - Wiley Online Library
Abdominal aortic aneurysm (AAA) is a common disease that, when surgical treatment is
inapplicable, results in rupture of the aorta with high mortality. Although nonsurgical …
inapplicable, results in rupture of the aorta with high mortality. Although nonsurgical …
Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase
K Yoshimura, H Aoki, Y Ikeda, K Fujii, N Akiyama… - Nature medicine, 2005 - nature.com
Abdominal aortic aneurysm (AAA) is a common disease among elderly people that, when
surgical treatment is inapplicable, results in progressive expansion and rupture of the aorta …
surgical treatment is inapplicable, results in progressive expansion and rupture of the aorta …
Identification of c‐Jun N‐terminal kinase as a therapeutic target for abdominal aortic aneurysm
K Yoshimura, H Aoki, Y Ikeda, A Furutani… - Annals of the New …, 2006 - Wiley Online Library
Despite the advances in molecular cell biology, identification of a therapeutic target in a
given disease still poses a significant challenge. Here we report a strategy for identification …
given disease still poses a significant challenge. Here we report a strategy for identification …
Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy
H Aoki, K Yoshimura, M Matsuzaki - Journal of Molecular Medicine, 2007 - Springer
Abdominal aortic aneurysm (AAA) is a common disease that causes progressive expansion
and rupture of the aorta with high mortality. There is a large and unmet need for nonsurgical …
and rupture of the aorta with high mortality. There is a large and unmet need for nonsurgical …
Recent advances in pharmacotherapy development for abdominal aortic aneurysm
K Yoshimura, H Aoki - International Journal of Vascular …, 2012 - Wiley Online Library
Abdominal aortic aneurysm (AAA) is a common disease causing segmental expansion and
rupture of the aorta with a high mortality rate. The lack of nonsurgical treatment represents a …
rupture of the aorta with a high mortality rate. The lack of nonsurgical treatment represents a …
[HTML][HTML] c‑Jun/Ap‑1 is upregulated in an Ang II‑induced abdominal aortic aneurysm formation model and mediates Chop expression in mouse aortic smooth muscle …
D Sun, M Zhang, Y Li, S Mei… - Molecular Medicine …, 2019 - spandidos-publications.com
Abdominal aortic aneurysm (AAA) is an asymptomatic, potentially lethal disease whose
ruptures have a high mortality rate. An effective pharmacological approach to decrease …
ruptures have a high mortality rate. An effective pharmacological approach to decrease …
[HTML][HTML] Pravastatin activates activator protein 2 alpha to augment the angiotensin II-induced abdominal aortic aneurysms
H Ma, WJ Liang, MR Shan, XQ Wang, SN Zhou… - Oncotarget, 2017 - ncbi.nlm.nih.gov
We have previously reported that activation of AMP-activated kinase alpha 2 (AMPKa2) by
nicotine or angiotensin II (AngII) instigates formation of abdominal aortic aneurysms (AAA) in …
nicotine or angiotensin II (AngII) instigates formation of abdominal aortic aneurysms (AAA) in …
[HTML][HTML] Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II
Clinical evidence links increased aortic collagen content and stiffness to abdominal aortic
aneurysm (AAA) formation. However, the possibility that excess collagen contributes to AAA …
aneurysm (AAA) formation. However, the possibility that excess collagen contributes to AAA …
Increased JNK in males compared with females in a rodent model of abdominal aortic aneurysm
PD DiMusto, G Lu, A Ghosh, KJ Roelofs… - Journal of Surgical …, 2012 - Elsevier
BACKGROUND: In humans, there is a 4: 1 male: female ratio in the incidence of abdominal
aortic aneurysms (AAAs). c-Jun-N-terminal kinase (JNK) is an important upstream regulator …
aortic aneurysms (AAAs). c-Jun-N-terminal kinase (JNK) is an important upstream regulator …
[HTML][HTML] Colchicine protects against the development of experimental abdominal aortic aneurysm
Y Zhao, QR Shen, YX Chen, Y Shi, WB Wu… - Clinical Science …, 2023 - ncbi.nlm.nih.gov
Abdominal aortic aneurysm (AAA) is characterized by at least 1.5-fold enlargement of the
infrarenal aorta, a ruptured AAA is life-threatening. Colchicine is a medicine used to treat …
infrarenal aorta, a ruptured AAA is life-threatening. Colchicine is a medicine used to treat …